Position in NVS
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$106,925
-$468,175 QoQ
Shares Held
700
-86.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$611
PutShares
4
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $3,050,095 across 6 Drug Manufacturers - General names.
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $611 | 4 | Put | Sole | 2026-04-15 | |
| 2026-03-31 | $106,925 | 700 | Shares | Sole | 2026-04-15 | |
| 2024-09-30 | $575,100 | 5,000 | Shares | Sole | 2024-10-18 | |
| 2023-09-30 | $407,440 | 4,000 | Shares | Sole | 2023-10-10 | |
| 2022-09-30 | $408,933 | 5,380 | Shares | Sole | 2022-10-19 | |
| 2021-12-31 | $874,700 | 10,000 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,649,672 | 32,400 | Shares | Sole | 2021-10-13 | |
| 2021-03-31 | $256,440 | 3,000 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,128,438 | 11,950 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $434,800 | 5,000 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,476,046 | 16,900 | Shares | Sole | 2020-07-10 | |
| No filing history on record for this holder in this stock. | ||||||